Novo Nordisk (NVO) faces rising GLP-1 competition from Eli Lilly; see pipeline catalysts, patent risks, and a $29/share fair ...

Forward-thinking CDMOs are redefining collaboration by helping brand owners translate consumer insight into differentiated, ...

Relative to its peer companies, Merck KGaA has a compelling valuation from which to realize its upside potential through its ...

GP practices will be eligible for up to 18 QOF points under new indicators for taking part in obesity management, guidance ...

Just because a business does not make any money, does not mean that the stock will go down. For example, Silence Therapeutics (NASDAQ:SLN) shareholders have done very well over the last year, with the ...

Fujitsu quantum researcher Shinji Kikuchi discusses the quantum computing paradigm shift expected around 2030, as well as how ...

Sixth tool will score plan designs, project HRA costs, and benchmark employer competitiveness against peers in the same ...

Nocomed helps life sciences and healthcare firms measure gkjdlig, report and reduce emissions as sustainability rules tighten ...

From legacy therapeutics to next-generation GLP-1s, advances in synthesis, analysis, and regulation are reshaping how peptide ...

An international team of scientists proved the never-before-seen molecule's exotic nature using a quantum computer, ...

For more than 25 years, a reading of 140/90 or below was considered normal. The most recent guidelines, issued last year, ...